Crystal Adam
CIK 1825445
Transactions on file
20
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-10-05 | 2026-10-01 | TNGX Tango Therapeutics, Inc. | President, R&D | Sale | 600 | $15.2K | +10.3% | open → |
| 2026-10-05 | 2026-10-01 | TNGX Tango Therapeutics, Inc. | President, R&D | Sale | 26,400 | $645.6K | +14.2% | open → |
| 2026-10-05 | 2026-10-01 | TNGX Tango Therapeutics, Inc. | President, R&D | Exer. | 27,000 | $140.4K | +437.1% | open → |
| 2026-09-03 | 2026-09-01 | TNGX Tango Therapeutics, Inc. | President, R&D | Sale | 27,000 | $603.9K | +24.9% | open → |
| 2026-09-03 | 2026-09-01 | TNGX Tango Therapeutics, Inc. | President, R&D | Exer. | 27,000 | $140.4K | +437.1% | open → |
| 2026-08-05 | 2026-08-03 | TNGX Tango Therapeutics, Inc. | President, R&D | Sale | 21,733 | $594.4K | +2.1% | open → |
| 2026-08-05 | 2026-08-03 | TNGX Tango Therapeutics, Inc. | President, R&D | Sale | 5,267 | $141.1K | +4.3% | open → |
| 2026-08-05 | 2026-08-03 | TNGX Tango Therapeutics, Inc. | President, R&D | Exer. | 27,000 | $140.4K | +437.1% | open → |
| 2026-06-03 | 2026-06-01 | TNGX Tango Therapeutics, Inc. | President, R&D | Sale | 20,860 | $480.9K | +21.1% | open → |
| 2026-06-03 | 2026-06-01 | TNGX Tango Therapeutics, Inc. | President, R&D | Sale | 6,140 | $136.6K | +25.5% | open → |
| 2026-06-03 | 2026-06-01 | TNGX Tango Therapeutics, Inc. | President, R&D | Exer. | 27,000 | $140.4K | +437.1% | open → |
| 2026-04-16 | 2026-04-15 | TNGX Tango Therapeutics, Inc. | President, R&D | Sale | 38,460 | $961.5K | +11.7% | open → |
| 2026-04-16 | 2026-04-15 | TNGX Tango Therapeutics, Inc. | President, R&D | Exer. | 38,460 | $200.0K | +437.1% | open → |
| 2025-02-05 | 2025-02-03 | TNGX Tango Therapeutics, Inc. | Officer See Remarks | Grant | 53,015 | $0.00 | — | open → |
| 2025-02-06 | 2025-02-04 | TNGX Tango Therapeutics, Inc. | Officer See Remarks | Sale | 7,432 | $22.2K | +834.1% | open → |
| 2025-02-06 | 2025-02-05 | TNGX Tango Therapeutics, Inc. | Officer See Remarks | Sale | 6,851 | $21.6K | +783.9% | open → |
| 2026-05-05 | 2026-05-01 | TNGX Tango Therapeutics, Inc. | President, R&D | Sale | 1,100 | $24.2K | +27.0% | open → |
| 2026-05-05 | 2026-05-01 | TNGX Tango Therapeutics, Inc. | President, R&D | Sale | 25,900 | $548.9K | +31.8% | open → |
| 2026-05-05 | 2026-05-01 | TNGX Tango Therapeutics, Inc. | President, R&D | Exer. | 27,000 | $140.4K | +437.1% | open → |
| 2026-03-09 | 2026-03-05 | TNGX Tango Therapeutics, Inc. | President, R&D | Sale | 20,251 | $303.8K | +86.2% | open → |
